AI framework helps identify new targets for CAR T cell therapy

Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers scientists' expertise to find viable target antigens for CAR T cell therapy.

The work was led by experts from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center and has been published in Cell. ...